SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:liu-48870"
 

Search: id:"swepub:oai:DiVA.org:liu-48870" > Long-term exposure ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Long-term exposure to telmisartan as monotherapy or combination therapy : Efficacy and safety

Freytag, F (author)
Kreiskrankenhaus Gunzenhausen, DE-91709 Gunzenhausen, Germany St Elizabeth Hosp, Dept Cardiol, Tilburg, Netherlands Univ Hosp, Dept Internal Med, Sect Endocrinol, Linkoping, Sweden Clin Res Boehringer Ingelheim Pharma KG, Biberach, Germany Ingelheim Pharma KG, Med Data Serv, Ingelheim, Germany
Holwerda, NJ (author)
Kreiskrankenhaus Gunzenhausen, DE-91709 Gunzenhausen, Germany St Elizabeth Hosp, Dept Cardiol, Tilburg, Netherlands Univ Hosp, Dept Internal Med, Sect Endocrinol, Linkoping, Sweden Clin Res Boehringer Ingelheim Pharma KG, Biberach, Germany Ingelheim Pharma KG, Med Data Serv, Ingelheim, Germany
Karlberg, BE (author)
Östergötlands Läns Landsting,Endokrin- och magtarmmedicinska kliniken
show more...
Meinicke, TW (author)
Kreiskrankenhaus Gunzenhausen, DE-91709 Gunzenhausen, Germany St Elizabeth Hosp, Dept Cardiol, Tilburg, Netherlands Univ Hosp, Dept Internal Med, Sect Endocrinol, Linkoping, Sweden Clin Res Boehringer Ingelheim Pharma KG, Biberach, Germany Ingelheim Pharma KG, Med Data Serv, Ingelheim, Germany
Schumacher, H (author)
Kreiskrankenhaus Gunzenhausen, DE-91709 Gunzenhausen, Germany St Elizabeth Hosp, Dept Cardiol, Tilburg, Netherlands Univ Hosp, Dept Internal Med, Sect Endocrinol, Linkoping, Sweden Clin Res Boehringer Ingelheim Pharma KG, Biberach, Germany Ingelheim Pharma KG, Med Data Serv, Ingelheim, Germany
show less...
 (creator_code:org_t)
2002
2002
English.
In: Blood Pressure. - 0803-7051 .- 1651-1999. ; 11:3, s. 173-181
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • This multicentre, open-label extension study to four controlled trials involved 888 patients with mild-to-moderate primary hypertension. Patients received telmisartan 40-80 mg once daily with add-on hydrochlorothiazide (HCTZ, 12.5-25 mg) if necessary and/or other antihypertensives to achieve diastolic blood pressure (DBP) control (

Keyword

combination treatment
primary hypertension-controlled trial
mono-therapy
telmisartan
hydrochlorothiazide
long-term safety
efficacy
NATURAL SCIENCES
NATURVETENSKAP

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Freytag, F
Holwerda, NJ
Karlberg, BE
Meinicke, TW
Schumacher, H
Articles in the publication
Blood Pressure
By the university
Linköping University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view